U.S. FDA puts Zafgen's diabetes trial on hold

1 分钟阅读

Nov 26 (Reuters) - Zafgen Inc said on Monday the U.S. Food and Drug Administration (FDA) had placed a clinical hold on the investigational new drug application for a trial of its experimental diabetes drug.

The company said the FDA had cited possible heart safety risks in its letter to the company last week. (Reporting by Manas Mishra in Bengaluru; Editing by Anil D'Silva)